Testing effectiveness (Phase 2)Study completedNCT02281500
What this trial is testing
Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia
Who this might be right for
Congenital Afibrinogenemia
Grifols Therapeutics LLC 24